Philips launches HyperVue Integrated System in the U.S., bringing advanced coronary imaging and physiology into the cathlab
Article excerpt
Highlighted: the sentence this signal was extracted from
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced U.S. commercial availability of the HyperVue Integrated System 1 , a new single room-based configuration of its HyperVue Imaging System for DeepOCT+NIRS imaging and X1-FFR physiology assessment. It is designed to keep advanced coronary imaging and physiology tools connected and readily available in the interventional suite. The system will be showcased at TCT 2026 in San Diego, California, October 31–November 3, alongside Philips' broader portfolio of imaging, physiology and procedural guidance solutions for precision PCI. "Every procedure is an opportunity to help a patient return to a fuller life, and physicians need technology that supports confident clinical decisions without adding unnecessary complexity or time," said Stacy Beske, Business Leader, Image Guided Therapy Devices at Philips. "For advanced intravascular imaging to become part of everyday practice, it has to fit naturally into the high-volume workflow of the interventional suite. Part of what Philips will showcase at TCT is how this approach extends across our portfolio, bringing imaging, physiology and procedural guidance closer together so physicians can access the information they need throughout the PCI procedure." Bringing physiology and intravascular imaging together HyperVue with...
Keep reading with a free account
The rest of this article, and every signal for Philips, is in your free account.